No products
View larger AT28081
1000 Items
| Quantity | mg | Unit Price ($/mg or $/Unit) | Final Price |
|---|---|---|---|
| 1 | 5 | $158.10 | Total: $790.50 |
| 1 | 10 | $133.92 | Total: $1,339.20 |
| 1 | 25 | $113.46 | Total: $2,836.50 |
| 1 | 50 | $96.72 | Total: $4,836.00 |
| 1 | 100 | $83.70 | Total: $8,370.00 |
| Molecular Formula | C34H29ClN6O3 |
| Molecular Weight | 605.09 |
| CAS Numbers | 122956-68-7 |
| Storage Condition | 0C Short Term, -20C Long Term |
| Solubility | DMSO |
| Purity | 98% by HPLC |
| SMILES Code | O=C(OCC)C1=C(NC(=C(C(=O)NC2=NC=CC=C2)C1C=3C=CC=CC3Cl)C)C=4C=CC(=CC4)N5C(=NC=6C=NC=CC65)C |
| References | Guerrero AT, Zarpelon AC, Vieira SM, Pinto LG, Ferreira SH, Cunha FQ, Verri WA Jr, Cunha TM. The role of PAFPAFR signaling in zymosan-induced articular inflammatory hyperalgesia. Naunyn Schmiedebergs Arch Pharmacol. 2013 Jan;386[1] 51-9. doi 10.1007s00210-012-0813-4. Erratum in Naunyn Schmiedebergs Arch Pharmacol. 2013 Apr;386[4] 351. Zaperlon, Ana C [corrected to Zarpelon, Ana C]. PubMed PMID 23187752. |